As of 2025-06-24, the Relative Valuation of HLS Therapeutics Inc (HLS.TO) is (11.36) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.96 CAD, the upside of HLS Therapeutics Inc based on Relative Valuation is -329.1%.
The range of the Relative Valuation is (7.48) - (12.45) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 20.8x | 16.6x |
| Forward P/E multiples | 7.5x - 15.9x | 12.4x |
| Fair Price | (7.48) - (12.45) | (11.36) |
| Upside | -250.8% - -351.0% | -329.1% |
| Date | P/E |
| 2025-06-20 | -6.35 |
| 2025-06-19 | -6.36 |
| 2025-06-18 | -6.35 |
| 2025-06-17 | -6.36 |
| 2025-06-16 | -6.39 |
| 2025-06-13 | -6.27 |
| 2025-06-12 | -6.34 |
| 2025-06-11 | -6.31 |
| 2025-06-10 | -6.34 |
| 2025-06-09 | -6.38 |
| 2025-06-06 | -6.30 |
| 2025-06-05 | -6.33 |
| 2025-06-04 | -6.27 |
| 2025-06-03 | -6.40 |
| 2025-06-02 | -6.47 |
| 2025-05-30 | -6.35 |
| 2025-05-29 | -6.34 |
| 2025-05-28 | -6.27 |
| 2025-05-27 | -6.47 |
| 2025-05-26 | -6.40 |
| 2025-05-23 | -5.99 |
| 2025-05-22 | -5.95 |
| 2025-05-21 | -6.03 |
| 2025-05-20 | -6.12 |
| 2025-05-16 | -6.15 |
| 2025-05-15 | -6.03 |
| 2025-05-14 | -6.16 |
| 2025-05-13 | -5.99 |
| 2025-05-12 | -5.76 |
| 2025-05-09 | -5.95 |
| 2025-05-08 | -5.89 |
| 2025-05-07 | -5.75 |
| 2025-05-06 | -5.57 |
| 2025-05-05 | -5.47 |
| 2025-05-02 | -5.63 |
| 2025-05-01 | -5.58 |
| 2025-04-30 | -5.43 |
| 2025-04-29 | -5.47 |
| 2025-04-28 | -5.56 |
| 2025-04-25 | -5.42 |
| 2025-04-24 | -5.34 |
| 2025-04-23 | -5.39 |
| 2025-04-22 | -5.44 |
| 2025-04-21 | -5.44 |
| 2025-04-17 | -5.38 |
| 2025-04-16 | -5.44 |
| 2025-04-15 | -5.48 |
| 2025-04-14 | -5.52 |
| 2025-04-11 | -5.16 |
| 2025-04-10 | -5.15 |